Alto Neuroscience (ANRO) Earnings Date, Estimates & Call Transcripts $2.33 +0.05 (+1.97%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$2.28 -0.05 (-1.94%) As of 04/25/2025 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alto Neuroscience Earnings Summary Upcoming Earnings DateMay. 13Before Market OpensEstimatedConsensus EPS (Mar. 20) -$0.65 Actual EPS (Mar. 20) -$0.56 Beat By $0.09 Alto Neuroscience posted Q4 2024 earnings on March 20, 2025, reporting an EPS of -$0.56, which topped the consensus estimate of -$0.65 by $0.09. With a trailing EPS of -$2.54, Alto Neuroscience's earnings are expected to grow next year, from ($2.54) to ($2.39) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)SEC FilingANRO Upcoming EarningsAlto Neuroscience's Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Alto Neuroscience Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alto Neuroscience and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataANRO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Alto Neuroscience Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.67-$0.45-$0.57Q2 20253-$0.69-$0.48-$0.59Q3 20253-$0.70-$0.62-$0.67Q4 20253-$0.72-$0.65-$0.69FY 202512-$2.78-$2.20-$2.52Q1 20262-$0.79-$0.53-$0.66Q2 20262-$0.81-$0.53-$0.67Q3 20262-$0.82-$0.43-$0.63Q4 20262-$0.65-$0.43-$0.54FY 20268($3.07)($1.92)($2.50) Alto Neuroscience Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)-------3/20/2025Q4 2024-$0.65-$0.56+$0.09-$0.56--11/12/2024--$0.67-$0.62+$0.05-$0.62--8/13/2024Q2 2024-$0.67-$0.60+$0.07-$0.60--5/14/2024Q1 2024-$0.46-$0.76 -$0.30-$0.76-- Alto Neuroscience Earnings - Frequently Asked Questions When is Alto Neuroscience's earnings date? Alto Neuroscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on ANRO's earnings history. Did Alto Neuroscience beat their earnings estimates last quarter? In the previous quarter, Alto Neuroscience (NYSE:ANRO) reported ($0.56) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.65) by $0.09. Learn more on analysts' earnings estimate vs. ANRO's actual earnings. How can I view Alto Neuroscience's earnings report? Alto Neuroscience's earnings report can be found in their filing with the SEC. View SEC filing How much profit does Alto Neuroscience generate each year? Alto Neuroscience (NYSE:ANRO) has a recorded net income of -$36.31 million. ANRO has generated -$2.54 earnings per share over the last four quarters. What is Alto Neuroscience's EPS forecast for next year? Alto Neuroscience's earnings are expected to grow from ($2.54) per share to ($2.39) per share in the next year. More Earnings Resources from MarketBeat Related Companies Compass Therapeutics Earnings Atea Pharmaceuticals Earnings Terns Pharmaceuticals Earnings Aurora Cannabis Earnings Solid Biosciences Earnings Astria Therapeutics Earnings Acelyrin Earnings Cidara Therapeutics Earnings Humacyte Earnings Bright Minds Biosciences Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Markets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Market Anticipation Builds: Joby Stock Climbs Ahead of EarningsIs Intuitive Surgical a Buy After Volatile Reaction to Earnings?Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout This page (NYSE:ANRO) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIElon Musk has done it again. He’s developed a powerful new AI model that’s already turning heads — and turn...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANRO Stock Free ANRO Stock Alerts